Position in HROW
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$326,437
New position
Shares Held
9,258
first reported quarter
Ownership
0.025%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Headlands Technologies LLC holds $7,923,247 across 14 Drug Manufacturers - Specialty & Generic names. HROW ranks #5 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
269,260 | $3,637,702 | |
| 2 | TLRY |
Tilray Brands, Inc.
|
175,060 | $1,132,638 | |
| 3 | ANIP |
Ani Pharmaceuticals Inc
|
9,830 | $755,927 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
72,652 | $691,647 | |
| 5 | HROW |
Harrow, Inc.
This page
|
9,258 | $326,437 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
19,814 | $275,414 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
20,478 | $254,541 | |
| 8 | HLN |
Haleon plc
|
23,242 | $232,652 |
All Filings in HROW
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $326,437 | 9,258 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||